Published in Proteomics on May 01, 2008
TGF-β3 modulates the inflammatory environment and reduces scar formation following vocal fold mucosal injury in rats. Dis Model Mech (2013) 0.97
Proteomic analysis of a decellularized human vocal fold mucosa scaffold using 2D electrophoresis and high-resolution mass spectrometry. Biomaterials (2012) 0.97
A historical and proteomic analysis of botulinum neurotoxin type/G. BMC Microbiol (2011) 0.88
Cross-sample validation provides enhanced proteome coverage in rat vocal fold mucosa. PLoS One (2011) 0.80
Proteomic changes in rat gastrocnemius muscle after botulinum toxin a injection. Ann Rehabil Med (2013) 0.79
Translational systems biology and voice pathophysiology. Laryngoscope (2010) 0.79
Enhancement of aging rat laryngeal muscles with endogenous growth factor treatment. Physiol Rep (2016) 0.75
Statistical methods for assessing agreement between two methods of clinical measurement. Lancet (1986) 211.50
High resolution two-dimensional electrophoresis of proteins. J Biol Chem (1975) 133.45
Measurement of protein using bicinchoninic acid. Anal Biochem (1985) 74.03
A simplified ultrasensitive silver stain for detecting proteins in polyacrylamide gels. Anal Biochem (1980) 24.76
Peroxiredoxins: a historical overview and speculative preview of novel mechanisms and emerging concepts in cell signaling. Free Radic Biol Med (2005) 5.83
Intramuscular injection of botulinum toxin for the treatment of wrist and finger spasticity after a stroke. N Engl J Med (2002) 5.34
Biological and clinical aspects of the vitamin D binding protein (Gc-globulin) and its polymorphism. Clin Chim Acta (2006) 2.97
Activation of superoxide dismutases: putting the metal to the pedal. Biochim Biophys Acta (2006) 2.33
Botulinum and tetanus neurotoxins: structure, function and therapeutic utility. Trends Biochem Sci (2002) 1.85
The Prohibitins: emerging roles in diverse functions. J Cell Mol Med (2006) 1.81
Efficacy and safety of botulinum type A toxin (Dysport) in cervical dystonia: results of the first US randomized, double-blind, placebo-controlled study. Mov Disord (2005) 1.54
Botulinum toxin-induced myopathy in the rat. Brain (1995) 1.43
Differential proteome analysis of aging in rat skeletal muscle. FASEB J (2005) 1.41
Botulinum toxin: mechanisms of action. Eur Neurol (2005) 1.16
Comparison of lidocaine injection, botulinum toxin injection, and dry needling to trigger points in myofascial pain syndrome. Rheumatol Int (2004) 1.14
Laryngeal-respiratory kinematics are impaired in aged rats. Ann Otol Rhinol Laryngol (2002) 1.07
Elongation factor Tu-targeted antibiotics: four different structures, two mechanisms of action. FEBS Lett (2006) 1.06
Regulation of the mitochondrial ATP-synthase in health and disease. Mol Genet Metab (2003) 1.02
Melanie II--a third-generation software package for analysis of two-dimensional electrophoresis images: I. Features and user interface. Electrophoresis (1997) 1.01
Melanie II--a third-generation software package for analysis of two-dimensional electrophoresis images: II. Algorithms. Electrophoresis (1997) 0.96
Botulinum toxin type B for cervical dystonia. Cochrane Database Syst Rev (2005) 0.95
Proteomic profiling reveals a severely perturbed protein expression pattern in aged skeletal muscle. Int J Mol Med (2007) 0.95
Quantitative protein profiling using two-dimensional gel electrophoresis, isotope-coded affinity tag labeling, and mass spectrometry. Mol Cell Proteomics (2002) 0.95
Enzymes catalyzing protein folding and their cellular functions. Curr Protein Pept Sci (2007) 0.90
Proteomic analysis of the atrophying rat soleus muscle following denervation. Electrophoresis (2000) 0.88
Investigation of differentially expressed proteins in rat gastrocnemius muscle during denervation-reinnervation. J Muscle Res Cell Motil (2006) 0.88
Proteomic analysis of rat soleus muscle undergoing hindlimb suspension-induced atrophy and reweighting hypertrophy. Proteomics (2002) 0.87
Separation and identification of rat skeletal muscle proteins using two-dimensional gel electrophoresis and mass spectrometry. Proteomics (2001) 0.87
Botox treatment in adductor spasmodic dysphonia: a meta-analysis. J Speech Lang Hear Res (2002) 0.86
Proteomic analysis of rat laryngeal muscle following denervation. Proteomics (2005) 0.86
Botulinum toxin type A therapy for blepharospasm. Cochrane Database Syst Rev (2005) 0.85
Botulinum toxin types A and B: comparison of efficacy, duration, and dose-ranging studies for the treatment of facial rhytides and hyperhidrosis. Clin Dermatol (2004) 0.84
Denervation of rabbit gastrocnemius and soleus muscles: effect on muscle-specific enolase. Eur J Biochem (1999) 0.84
Physiologic assessment of botulinum toxin effects in the rat larynx. Laryngoscope (1998) 0.83
Muscle fiber-type changes induced by botulinum toxin injection in the rat larynx. Otolaryngol Head Neck Surg (1999) 0.83
Mechanism of action of botulinum toxin type A in migraine prevention: a pilot study. Headache (2004) 0.82
Proteomic profiling of rat thyroarytenoid muscle. J Speech Lang Hear Res (2006) 0.80
Efficacy of repeated botulinum toxin injections as a function of timing. Ann Otol Rhinol Laryngol (1997) 0.80
Botulinum toxin type B: a new therapy for axillary hyperhidrosis. Br J Plast Surg (2005) 0.79
Increased acute and chronic mitotic activity in rat laryngeal muscles after botulinum toxin injection. Laryngoscope (1998) 0.79
The effect of botulinum toxin type-A injection on spasticity, range of motion and gait patterns in children with spastic diplegic cerebral palsy: an Egyptian study. Int J Rehabil Res (2004) 0.78
Transoral electromyographic recordings in botulinum toxin-injected rat larynges. Ann Otol Rhinol Laryngol (1997) 0.78
Histology of nerves and muscles in adductor spasmodic dysphonia. Ann Otol Rhinol Laryngol (2003) 0.77
Current treatments for axillary hyperhidrosis. Surgeon (2004) 0.77
Mechanism of shape determination in motile cells. Nature (2008) 4.90
Histologic and rheologic characterization of vocal fold scarring. J Voice (2002) 1.94
Analysis of protein interactions using fluorescence technologies. Curr Opin Chem Biol (2003) 1.91
Trisoxazole macrolide toxins mimic the binding of actin-capping proteins to actin. Nat Struct Biol (2003) 1.62
Histologic characterization of rat vocal fold scarring. Ann Otol Rhinol Laryngol (2005) 1.61
Synthetic mimetics of actin-binding macrolides: rational design of actin-targeted drugs. Chem Biol (2008) 1.61
Optical lock-in detection of FRET using synthetic and genetically encoded optical switches. Biophys J (2008) 1.50
Characterization of chronic vocal fold scarring in a rabbit model. J Voice (2004) 1.48
Histological study of acute vocal fold injury in a rat model. Ann Otol Rhinol Laryngol (2006) 1.47
Immediate inflammatory response and scar formation in wounded vocal folds. Ann Otol Rhinol Laryngol (2006) 1.45
Characterization of vocal fold scarring in a canine model. Laryngoscope (2003) 1.44
Family of site-selective molecular optical switches. J Org Chem (2005) 1.41
A rat excised larynx model of vocal fold scar. J Speech Lang Hear Res (2009) 1.37
A Lim protein involved in the progression of cytokinesis and regulation of the mitotic spindle. Cell Motil Cytoskeleton (2003) 1.34
Inflammatory factor profiles one hour following vocal fold injury. Ann Otol Rhinol Laryngol (2008) 1.33
Biomolecular mimicry in the actin cytoskeleton: mechanisms underlying the cytotoxicity of kabiramide C and related macrolides. Proc Natl Acad Sci U S A (2003) 1.33
Optical switching of dipolar interactions on proteins. Proc Natl Acad Sci U S A (2005) 1.28
Prevention of vocal fold scarring by topical injection of hepatocyte growth factor in a rabbit model. Laryngoscope (2004) 1.28
Long-term outcome of transoral organ-preserving pharyngeal endoscopic resection for superficial pharyngeal cancer. Gastrointest Endosc (2011) 1.18
Fabrication of histidine-tagged fusion protein arrays for surface plasmon resonance imaging studies of protein-protein and protein-DNA interactions. Anal Chem (2003) 1.17
Cell production in injured vocal folds: a rat study. Ann Otol Rhinol Laryngol (2006) 1.15
Alteration in cellular morphology, density and distribution in rat vocal fold mucosa following injury. Wound Repair Regen (2009) 1.10
Hyaluronan levels in acute vocal fold scar. Laryngoscope (2004) 1.10
Interstitial protein alterations in rabbit vocal fold with scar. J Voice (2003) 1.10
Structural basis of swinholide A binding to actin. Chem Biol (2005) 1.09
Optically switchable chelates: optical control and sensing of metal ions. J Org Chem (2007) 1.09
Therapeutic potential of growth factors for aging voice. Laryngoscope (2004) 1.08
Absolute stereochemistry of ulapualide A. Org Lett (2004) 1.07
Growth factor therapy for vocal fold scarring in a canine model. Ann Otol Rhinol Laryngol (2004) 1.07
Collagen subtypes in human vocal folds. Ann Otol Rhinol Laryngol (2006) 1.06
Effect of growth factors on hyaluronan production by canine vocal fold fibroblasts. Ann Otol Rhinol Laryngol (2003) 1.06
Viscoelastic measurements of vocal folds using the linear skin rheometer. J Voice (2007) 1.06
Cooperative functions of Hes/Hey genes in auditory hair cell and supporting cell development. Dev Biol (2011) 1.04
Fluorescent kabiramides: new probes to quantify actin in vitro and in vivo. Bioconjug Chem (2005) 1.03
Functional outcomes of reduced hyaluronan in acute vocal fold scar. Ann Otol Rhinol Laryngol (2004) 1.01
Trophic support of mouse inner ear by neural stem cell transplantation. Neuroreport (2003) 1.01
Cortical correlates of vestibulo-ocular reflex modulation: a PET study. Brain (2003) 0.98
A novel technique for inducing local inner ear damage. Hear Res (2003) 0.98
Age-related alterations in myosin heavy chain isoforms in rat intrinsic laryngeal muscles. Ann Otol Rhinol Laryngol (2002) 0.97
Fibronectin and adhesion molecules on canine scarred vocal folds. Laryngoscope (2003) 0.95
Optical switch probes and optical lock-in detection (OLID) imaging microscopy: high-contrast fluorescence imaging within living systems. Biochem J (2011) 0.94
Investigation of anti-hyaluronidase treatment on vocal fold wound healing. J Voice (2005) 0.93
Rational design, synthesis, and characterization of highly fluorescent optical switches for high-contrast optical lock-in detection (OLID) imaging microscopy in living cells. Bioorg Med Chem (2010) 0.93
Morphological and extracellular matrix changes following vocal fold injury in mice. Cells Tissues Organs (2010) 0.92
Prospective multi-arm evaluation of surgical treatments for vocal fold scar and pathologic sulcus vocalis. Laryngoscope (2011) 0.92
Regeneration of radiation damaged salivary glands with adipose-derived stromal cells. Laryngoscope (2011) 0.91
Transplantation of neural stem cells into the modiolus of mouse cochleae injured by cisplatin. Acta Otolaryngol Suppl (2004) 0.90
Increased expression of phosphatidylcholine (16:0/18:1) and (16:0/18:2) in thyroid papillary cancer. PLoS One (2012) 0.90
Adipose-derived stem cells versus bone marrow-derived stem cells for vocal fold regeneration. Laryngoscope (2014) 0.89
Glottal configuration, acoustic, and aerodynamic changes induced by variation in suture direction in arytenoid adduction procedures. Ann Otol Rhinol Laryngol (2002) 0.89
Treatment of vocal fold scarring: rheological and histological measures of homologous collagen matrix. Ann Otol Rhinol Laryngol (2002) 0.89
Regeneration of aged vocal folds with basic fibroblast growth factor in a rat model: a preliminary report. Ann Otol Rhinol Laryngol (2005) 0.88
Transforming growth factor β3 for the prevention of vocal fold scarring. Laryngoscope (2012) 0.88
Clinical trial of regeneration of aged vocal folds with growth factor therapy. Laryngoscope (2012) 0.87
Surgical techniques for cell transplantation into the mouse cochlea. Acta Otolaryngol Suppl (2004) 0.87
Attitudes of children with dysphonia. J Voice (2007) 0.87
Implantation of an atelocollagen sponge with autologous bone marrow-derived mesenchymal stromal cells for treatment of vocal fold scarring in a canine model. Ann Otol Rhinol Laryngol (2011) 0.87
Structural dynamics of troponin I during Ca2+-activation of cardiac thin filaments: a multi-site Förster resonance energy transfer study. PLoS One (2012) 0.86
Fluorescence resonance energy transfer imaging microscopy and fluorescence polarization imaging microscopy. Methods Enzymol (2003) 0.85
Effects of basic fibroblast growth factor on rat vocal fold fibroblasts. Ann Otol Rhinol Laryngol (2010) 0.85
Chronic vocal fold scar restoration with hepatocyte growth factor hydrogel. Laryngoscope (2010) 0.85
Tropomyosin dynamics in cardiac thin filaments: a multisite forster resonance energy transfer and anisotropy study. Biophys J (2008) 0.85
Postnatal development of rat vocal folds. Ann Otol Rhinol Laryngol (2006) 0.85
Temporal changes in vocal functions of human scarred vocal folds after cordectomy. Laryngoscope (2010) 0.85
Expression of reactive oxygen species during wound healing of vocal folds in a rat model. Ann Otol Rhinol Laryngol (2012) 0.84
Morphological and functional changes of human vocal fold fibroblasts with hepatocyte growth factor. Ann Otol Rhinol Laryngol (2003) 0.84
Influence of vocal fold scarring on phonation: predictions from a finite element model. Ann Otol Rhinol Laryngol (2005) 0.84
Hedgehog signaling regulates prosensory cell properties during the basal-to-apical wave of hair cell differentiation in the mammalian cochlea. Development (2013) 0.84
Ten years single institutional experience of treatment for advanced hypopharyngeal cancer in Kyoto University. Acta Otolaryngol Suppl (2010) 0.84
Fiberoptic laryngeal surgery for vocal process granuloma. Ann Otol Rhinol Laryngol (2002) 0.84
Effect of astaxanthin on vocal fold wound healing. Laryngoscope (2013) 0.83
Actin can act as a cofactor for a viral proteinase in the cleavage of the cytoskeleton. J Biol Chem (2002) 0.83
Optical control of calcium affinity in a spiroamido-rhodamine based calcium chelator. Org Lett (2011) 0.83
Surgical method to create vocal fold injuries in mice. Ann Otol Rhinol Laryngol (2009) 0.83
Nonlinear dynamic-based analysis of severe dysphonia in patients with vocal fold scar and sulcus vocalis. J Voice (2012) 0.83
Determination of phonation instability pressure and phonation pressure range in excised larynges. J Speech Lang Hear Res (2007) 0.83
Voice handicap evaluation of patients with pathologic sulcus vocalis. Ann Otol Rhinol Laryngol (2007) 0.83
The protective efficacy of basic fibroblast growth factor in radiation-induced salivary gland dysfunction in mice. Laryngoscope (2011) 0.82
Ten years single institutional experience of treatment for advanced laryngeal cancer in Kyoto University. Acta Otolaryngol Suppl (2010) 0.82
[A study of salivary gland aspiration cytology reporting: guideline validity]. Nihon Jibiinkoka Gakkai Kaiho (2011) 0.81
Prevention of buccal mucosa scarring with transforming growth factor β3. Laryngoscope (2011) 0.81
Differential vibratory characteristics of adductor spasmodic dysphonia and muscle tension dysphonia on high-speed digital imaging. Ann Otol Rhinol Laryngol (2011) 0.81
Effect of exogenous hepatocyte growth factor on vocal fold fibroblasts. Ann Otol Rhinol Laryngol (2009) 0.81
Changes in cytokine signaling and extracellular matrix production induced by inflammatory factors in cultured vocal fold fibroblasts. Ann Otol Rhinol Laryngol (2008) 0.81
Vitamin A deficiency causes metaplasia in vocal fold epithelium: a rat study. Ann Otol Rhinol Laryngol (2008) 0.81
Structural and biochemical studies of actin in complex with synthetic macrolide tail analogues. ChemMedChem (2014) 0.81
Recurrence patterns after postoperative radiotherapy for squamous cell carcinoma of the pharynx and larynx. Acta Otolaryngol (2014) 0.80
Ten years single institutional experience of treatment for oral cancer in Kyoto University. Acta Otolaryngol Suppl (2010) 0.80
Probing conformational changes of prestin with thiol-reactive optical switches. Biophys J (2008) 0.80
Proteomic profiling of rat thyroarytenoid muscle. J Speech Lang Hear Res (2006) 0.80